1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 19,500 | 19,600 | 07:07 | |
| 19,100 | 19,900 | 07:09 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.02. | Anbio Biotechnology - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 26.01. | Anbio Biotechnology - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 30.12.25 | Anbio Biotechnology - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.08.25 | Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System | 176 | GlobeNewswire (Europe) | FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering... ► Artikel lesen | |
| ANBIO BIOTECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 14.03.25 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 14.03.2025 | 1.120 | Xetra Newsboard | The following instruments on XETRA do have their first trading 14.03.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.03.2025
Aktien
1 KYG0367B1059 Anbio Biotechnology
2... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORGANIGRAM GLOBAL | 1,140 | -5,00 % | Organigram Global Inc: Organigram launches Edison, Boxhot in Australia | ||
| ASSEMBLY BIOSCIENCES | 25,200 | -0,40 % | Assembly Biosciences: Top-Favorit 2026 - darum bin ich wieder voll dabei! | Alte Liebe rostet nicht: Nach zwischenzeitlich +412% Kursgewinn im vergangenen Jahr und massiven Gewinnmitnahmen habe ich mich als Ex-Großaktionär erneut in erheblichem Umfang bei Assembly Biosciences... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 140,45 | -1,27 % | Axsome Therapeutics auf Oppenheimer-Konferenz: Wachstumsstrategie im Fokus | ||
| COMPASS PATHWAYS | 6,050 | +0,83 % | Compass Pathfinder Limited: Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were... ► Artikel lesen | |
| ALTIMMUNE | 3,605 | +1,41 % | Forget Altimmune: This Proven Obesity-Drug Giant Is the Better Weight-Loss Play | ||
| ACHIEVE LIFE SCIENCES | 3,825 | -3,16 % | Achieve Life Sciences: Entscheidet der 20. Juni über Leben und Tod? | Seit unseres Trading-Tipps im Juli letzten Jahres konnte die Aktie von Achieve Life Sciences zwischenzeitlich über +150% zulegen, korrigierte in den letzten Wochen aber wieder um mehr als 20%. Das Unternehmen... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 4,360 | +0,81 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) | Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,312 | -9,04 % | XORTX Therapeutics Inc. - 6-K, Report of foreign issuer | ||
| KALA BIO | 0,340 | +1,73 % | KALA BIO, Inc.: KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint | -- Study did not meet primary endpoint of complete healing of PCED at Week 8; secondary endpoints also did not achieve statistical significance -- -- KPI-012 was well-tolerated with no treatment-related... ► Artikel lesen | |
| SCYNEXIS | 0,624 | -2,50 % | SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247 | JERSEY CITY, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant... ► Artikel lesen | |
| WAVE LIFE SCIENCES | 11,700 | -0,85 % | Wave Life Sciences Ltd.: Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while... ► Artikel lesen | |
| GALECTIN THERAPEUTICS | 2,660 | +1,53 % | Galectin Therapeutics Inc.: Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March ... | NORCROSS, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension... ► Artikel lesen | |
| IRONWOOD PHARMACEUTICALS | 3,060 | 0,00 % | IRONWOOD PHARMACEUTICALS INC - 10-K, Annual Report | ||
| XERIS BIOPHARMA | 5,485 | -1,35 % | Xeris Biopharma Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| NEUROGENE | 20,600 | +16,45 % | Morning Market Movers: Neurogene, Duolingo, Xponential Fitness, Emergent BioSolutions See Big Swings | WASHINGTON (dpa-AFX) - At 6:22 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
ANBIO BIOTECHNOLOGY gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -1,200 (-5,41 %) liegt der Kurs bei 21,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ANBIO BIOTECHNOLOGY finden Sie auf Wallstreet Online.